ArticleNature communications2019

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.

Jennifer Karin Ocasio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.